approval
saveRENFLEXIS (INFLIXIMAB-ABDA) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 5
- approvalRENFLEXIS (INFLIXIMAB-ABDA) — FDA approvalDec 26, 2023 · 1013d ago
- approvalRENFLEXIS (INFLIXIMAB-ABDA) — FDA approvalJan 27, 2022 · 1711d ago
- approvalRENFLEXIS (INFLIXIMAB-ABDA) — FDA approvalJun 26, 2019 · 2657d ago
- approvalRENFLEXIS (INFLIXIMAB-ABDA) — FDA approvalMar 21, 2019 · 2754d ago
- approvalRENFLEXIS (INFLIXIMAB-ABDA) — FDA approvalApr 21, 2017 · 3453d ago
same company · ±60 days · 6
- approvaldenosumab biosimilar: DENOSUMAB-DSSB — FDA approvalOct 29, 2025
- recallSamsung Bioepis Co., Ltd. recall (Cls II)Nov 5, 2025
- approvalHADLIMA: HADLIMA (ADALIMUMAB-BWWD) — FDA approvalOct 17, 2025
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 10, 2025
- approvalBYOOVIZ: BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalNov 12, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalNov 18, 2025
comments(0)
5-min edit window · permanent after that